Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.532
-0.015 (-2.80%)
Mar 9, 2026, 3:39 PM EDT - Market open
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $1.93 million as of March 9, 2026. Its market cap has decreased by -73.54% in one year.
Market Cap
1.93M
Enterprise Value
593.48K
1-Year Change
-73.54%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since December 1, 2017, Ensysce Biosciences's market cap has decreased from $249.00M to $1.93M, a decrease of -99.22%. That is a compound annual growth rate of -44.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.90M | -42.42% |
| Dec 31, 2025 | 3.30M | -68.87% |
| Dec 31, 2024 | 10.60M | 221.21% |
| Dec 29, 2023 | 3.30M | -40.00% |
| Dec 30, 2022 | 5.50M | -95.18% |
| Dec 31, 2021 | 114.00M | 46.34% |
| Dec 31, 2020 | 77.90M | -70.10% |
| Dec 31, 2019 | 260.50M | 6.11% |
| Dec 31, 2018 | 245.50M | -0.89% |
| Dec 29, 2017 | 247.70M | -0.52% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 2.64M |
| 60 Degrees Pharmaceuticals | 2.64M |
| Artelo Biosciences | 2.42M |
| PMGC Holdings | 2.40M |
| Bone Biologics | 2.30M |
| Lyra Therapeutics | 2.27M |
| Clearmind Medicine | 2.05M |
| Adial Pharmaceuticals | 2.03M |